November 12, 2024

Drug Discovery Services Market May See a Big Move In The Coming Future

The drug discovery services market is projected to grow from USD 14.11 billion in 2022 and is forecasted to reach USD 33.2 billion by 2030; it is expected to grow at a CAGR of 11.3% from 2021 to 2030.

Drug Discovery Services Market Size 2020 to 2030

The study provides an analysis of the period 2017-2030, wherein 2021 to 2030 is the forecast period and 2021 is considered as the base year.

The global drug discovery services market is primarily driven by the increased investments in the research & development activities by the pharmaceutical and biologics companies across the globe. The rising prevalence of various disease and growing geriatric population across the globe are the major contributors to the demand for the pharmaceutical drugs. As per the United Nations, the geriatric population across the globe is estimated to reach 2 billion by 2050.

The elderly people are more susceptible to chronic diseases and hence spend more on the life-saving drugs. The increased need for the development of new and innovative drugs for the treatment of various common and rare diseases is fueling the demand for the drug discovery services. The patents expiry and growing demand for the biopharmaceutical drugs in the emerging economies is expected to drive the growth of the global drug discovery services market during the forecast period.

Get a Free Sample Copy of this Report with Global Industry Analysis @ https://www.precedenceresearch.com/sample/1532

Scope of the Drug Discovery Services Market
Report Coverage Details
Base Year 2021
Forecast Period 2021 to 2030
Largest Market North America
Fastest Growing Market Asia Pacific
Segments Covered Drug Type, Process, Type,Therapeutic Area, Region
Drug Discovery Services Market Estimations Y-O-Y:
  • Market Size Was Valued In 2021: US$ 12.68 Billion
  • Market Size Is Projected to Grow By 2022: US$ 14.11 Billion
  • Market Size Is Projected to Grow By 2023: US$ 15.7 Billion
  • Market Size Is Projected to Grow By 2024: US$ 17.47 Billion
  • Market Size Is Projected to Grow By 2025: US$ 19.44 Billion
  • Market Size Is Projected to Grow By 2026: US$ 21.64 Billion
  • Market Size Is Projected to Grow By 2027: US$ 24.08 Billion
  • Market Size Is Projected to Grow By 2028: US$ 26.81 Billion
  • Market Size Is Projected to Grow By 2029: US$ 29.85 Billion
  • Market Size Is Projected to Grow By 2030: US$ 33.2 Billion
  • Compound Annual Growth Rate (CAGR) from 2022 to 2030: 11.3 percent
Drug Discovery Services Market Report Highlights
  • Based on the drug type, the small molecules segment dominated the market in 2020, owing to its increased demand among the patients. The small molecules can effectively treat the infected cells with low or no side-effects, which makes it a popular drug among the population.
  • Based on the type, the medicinal chemistry segment dominated the market in 2020. This is attributable to the increased applications of the medicinal chemistry from pre-clinical trials to the candidate delivery. The rising investments by the pharmaceutical companies in the drug discovery services are boosting the growth of this segment.
  • Based on the therapeutic area, the oncology segment dominated the market in 2020. This is attributed to the increased prevalence of cancer among the population. According to the International Agency for Research on Cancer, around 19.3 million new cancer cases and around 10 million cancer deaths were reported in 2020. The new cancer cases are expected to rise by 47% from 2020 to 2040, globally.
Drug Discovery Services Market Dynamics

Driver

Increasing R & D expenditure by the pharmaceutical companies

According to the International Federation of Pharmaceutical Manufacturers & Associations, the pharmaceutical industry spent around US$150 billion in the research & development activities. It is estimated that on an average, a pharmaceutical company spends around 17% of its revenues on the research & development. Therefore, the rapidly growing pharmaceutical industry and surging investments by them in the R&D is expected to drive the growth of the global drug discovery services market during the forecast period.

Restraint

High costs associated with the drug discovery

A huge cost is involved in the services of drug discovery, owing to the higher attrition rate of the candidates during the development phase. Moreover, the research related to rare diseases requires a specific candidates’ group for the clinical trials. Moreover, the success rate is very low and the number of drugs that receives approval is very low. This involves a huge cost.

Opportunity

Rapidly growing biologics industry

The biologics industry has produced several life-saving innovative drugs that can cure chronic diseases such as cancer, diabetes, and CVDs. The rising awareness regarding the biologics is boosting the demand for the biologics. The biopharmaceuticals alone accounts for 20% of the pharmaceutical industry and is rapidly growing, which offers immense growth opportunities to the market players.

Challenge

Higher attrition rate of the candidates

The most difficult task in the drug discovery services is the identification and retention of the candidates in the clinical trials phase. The higher attrition rate of the candidates is a major challenge for the market players.

Regional Snapshot

In 2020, North America dominated the glob al drug discover services market. The increased prevalence of various chronic diseases in US is a major factor that attracts the investments from the pharmaceutical companies towards the research and drug discovery activities. As peer the CDC, around 92.1 million adults in US are suffering from at least one type of cardiovascular disease. It is estimated that over half of the US population is suffering from at least one chronic disease such as cancer, CVDs, respiratory diseases, and neurological disorders.

This results in the increased demand for the new and innovative drugs. Moreover, as per the Population Reference Bureau, the number of people aged 65 years and above is expected to reach at 95 million in US by 2060. The geriatric people has higher demand for the various life-saving drugs as they are more prone to various diseases. The presence of several top pharmaceutical companies in the region results in the increased investments towards the drug discovery activities.

Asia Pacific is estimated to be the most opportunistic market during the forecast period. The rising investments by the top global players in the region owing to the cheap availability of factors of production, availability of several top research companies, and favorable government regulations are collectively driving the growth of the drug discovery services market. The rising geriatric population and rising prevalence of chronic diseases due to various reasons is supplementing the demand for the innovative life-saving drugs, which fuels the investments towards the drug discovery services.

Read Also: Ear Nose Throat (ENT) Treatment Market to Reach US$ 27.95 billion by 2030

Some of the prominent players in the global drug discovery services market include:
  • Abbott Laboratories Inc.
  • Advinus Therapeutics
  • Agilent Technologies Ubiquigent
  • Albany Molecular Research Inc.
  • AstraZeneca PLC
  • Aurigene
  • Bayer AG
  • Charles River Laboratories International
  • ChemBridge Corporation
  • Covance
Market Segmentation

By Process

  • Target Selection
  • Target Validation
  • Hit to Lead Identification
  • Lead Optimization
  • Candidate Validation

By Drug Type

  • Small Molecules
  • Biologics

By Type

  • DMPK
  • Biology Services
  • Medicinal Chemistry

By Therapeutic Area

  • Oncology
  • Cardiovascular Diseases
  • Diabetes
  • Neurology
  • Respiratory Diseases
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa
TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Drug Discovery Services Market 

5.1. COVID-19 Landscape: Drug Discovery Services Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Drug Discovery Services Market, By Process

8.1. Drug Discovery Services Market, by Process Type, 2021-2030

8.1.1. Target Selection

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Target Validation

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Hit to Lead Identification

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Lead Optimization

8.1.4.1. Market Revenue and Forecast (2019-2030)

8.1.5. Candidate Validation

8.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Drug Discovery Services Market, By Drug Type

9.1. Drug Discovery Services Market, by Drug Type, 2021-2030

9.1.1. Small Molecules

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Biologics

9.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Drug Discovery Services Market, By Type

10.1. Drug Discovery Services Market, by Type, 2021-2030

10.1.1. DMPK

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Biology Services

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. Medicinal Chemistry

10.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Drug Discovery Services Market, By Therapeutic Area

11.1. Drug Discovery Services Market, by Therapeutic Area Type, 2021-2030

11.1.1. Oncology

11.1.1.1. Market Revenue and Forecast (2019-2030)

11.1.2. Cardiovascular Diseases

11.1.2.1. Market Revenue and Forecast (2019-2030)

11.1.3. Diabetes

11.1.3.1. Market Revenue and Forecast (2019-2030)

11.1.4. Neurology

11.1.4.1. Market Revenue and Forecast (2019-2030)

11.1.5. Respiratory Diseases

11.1.5.1. Market Revenue and Forecast (2019-2030)

11.1.6. Others

11.1.6.1. Market Revenue and Forecast (2019-2030)

Chapter 12. Global Drug Discovery Services Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Process (2019-2030)

12.1.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.1.3. Market Revenue and Forecast, by Type (2019-2030)

12.1.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Process (2019-2030)

12.1.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.1.5.3. Market Revenue and Forecast, by Type (2019-2030)

12.1.5.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Process (2019-2030)

12.1.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.1.6.3. Market Revenue and Forecast, by Type (2019-2030)

12.1.6.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Process (2019-2030)

12.2.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.2.3. Market Revenue and Forecast, by Type (2019-2030)

12.2.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Process (2019-2030)

12.2.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.2.5.3. Market Revenue and Forecast, by Type (2019-2030)

12.2.5.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Process (2019-2030)

12.2.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.2.6.3. Market Revenue and Forecast, by Type (2019-2030)

12.2.6.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Process (2019-2030)

12.2.7.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.2.7.3. Market Revenue and Forecast, by Type (2019-2030)

12.2.7.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Process (2019-2030)

12.2.8.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.2.8.3. Market Revenue and Forecast, by Type (2019-2030)

12.2.8.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Process (2019-2030)

12.3.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.3.3. Market Revenue and Forecast, by Type (2019-2030)

12.3.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Process (2019-2030)

12.3.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.3.5.3. Market Revenue and Forecast, by Type (2019-2030)

12.3.5.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Process (2019-2030)

12.3.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.3.6.3. Market Revenue and Forecast, by Type (2019-2030)

12.3.6.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Process (2019-2030)

12.3.7.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.3.7.3. Market Revenue and Forecast, by Type (2019-2030)

12.3.7.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Process (2019-2030)

12.3.8.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.3.8.3. Market Revenue and Forecast, by Type (2019-2030)

12.3.8.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Process (2019-2030)

12.4.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.4.3. Market Revenue and Forecast, by Type (2019-2030)

12.4.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Process (2019-2030)

12.4.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.4.5.3. Market Revenue and Forecast, by Type (2019-2030)

12.4.5.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Process (2019-2030)

12.4.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.4.6.3. Market Revenue and Forecast, by Type (2019-2030)

12.4.6.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Process (2019-2030)

12.4.7.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.4.7.3. Market Revenue and Forecast, by Type (2019-2030)

12.4.7.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Process (2019-2030)

12.4.8.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.4.8.3. Market Revenue and Forecast, by Type (2019-2030)

12.4.8.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Process (2019-2030)

12.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.5.3. Market Revenue and Forecast, by Type (2019-2030)

12.5.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Process (2019-2030)

12.5.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.5.5.3. Market Revenue and Forecast, by Type (2019-2030)

12.5.5.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Process (2019-2030)

12.5.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)

12.5.6.3. Market Revenue and Forecast, by Type (2019-2030)

12.5.6.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)

Chapter 13. Company Profiles

13.1. Abbott Laboratories Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Advinus Therapeutics

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Agilent Technologies Ubiquigent

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Albany Molecular Research Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. AstraZeneca PLC

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Aurigene

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Bayer AG

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Charles River Laboratories International

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. ChemBridge Corporation

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Covance

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global drug discovery services market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for drug discovery services are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1532

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Daily Tech Daily Tech

Daily Tech Bulletin is one of the leading newswire distribution networks, specializing in the delivery of corporate press releases, financial announcements, and multimedia content to media, investors, and consumers worldwide. US Web Wire covers all significant healthcare news, technology, and automotive news. We also publish a wide range of market research articles, press releases, white papers, and case studies.

View all posts by Daily Tech Daily Tech →

Leave a Reply

Your email address will not be published. Required fields are marked *